nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjuvant therapy and thrombosis: How to avoid the problem?
|
Levine, Mark N. |
|
2007 |
16 |
S2 |
p. 169-174 6 p. |
artikel |
2 |
Adjuvant therapy of the very young woman
|
Pritchard, Kathleen I. |
|
2007 |
16 |
S2 |
p. 136-146 11 p. |
artikel |
3 |
Adjuvant treatment of elderly breast cancer patients
|
Muss, H.B. |
|
2007 |
16 |
S2 |
p. 159-165 7 p. |
artikel |
4 |
Angiogenesis as targeted breast cancer therapy
|
Hayes, Daniel F. |
|
2007 |
16 |
S2 |
p. 17-19 3 p. |
artikel |
5 |
Application of aromatase inhibitors in endocrine responsive breast cancers
|
Goss, Paul |
|
2007 |
16 |
S2 |
p. 114-119 6 p. |
artikel |
6 |
Benefit from adjuvant taxanes and endocrine responsiveness in breast cancer
|
Martin, Miguel |
|
2007 |
16 |
S2 |
p. 127-131 5 p. |
artikel |
7 |
Breast cancer and pregnancy
|
Ring, Alistair |
|
2007 |
16 |
S2 |
p. 155-158 4 p. |
artikel |
8 |
Breast surgery in advanced breast cancer: Local control in the presence of metastases
|
Wood, William C. |
|
2007 |
16 |
S2 |
p. 63-66 4 p. |
artikel |
9 |
Cognitive side-effects of adjuvant treatments
|
Burstein, Harold J. |
|
2007 |
16 |
S2 |
p. 166-168 3 p. |
artikel |
10 |
Controversies in the use of sentinel nodes: Microinvasion, post surgery and after preoperative systemic treatment
|
Veronesi, Paolo |
|
2007 |
16 |
S2 |
p. 67-70 4 p. |
artikel |
11 |
Current status of the taxanes as adjuvant therapy for breast cancer
|
Hudis, Clifford |
|
2007 |
16 |
S2 |
p. 132-135 4 p. |
artikel |
12 |
Disseminated tumor cells: Are they ready for clinical use?
|
Braun, Stephan |
|
2007 |
16 |
S2 |
p. 51-54 4 p. |
artikel |
13 |
Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients
|
Craig Jordan, V. |
|
2007 |
16 |
S2 |
p. 105-113 9 p. |
artikel |
14 |
Fertility and adjuvant treatment in young women with breast cancer
|
Partridge, Ann H. |
|
2007 |
16 |
S2 |
p. 175-181 7 p. |
artikel |
15 |
Follow-up care of patients with breast cancer
|
Tolaney, Sara M. |
|
2007 |
16 |
S2 |
p. 45-50 6 p. |
artikel |
16 |
How to treat male breast cancer
|
Kamila, Czene |
|
2007 |
16 |
S2 |
p. 147-154 8 p. |
artikel |
17 |
Immunology and breast cancer: Therapeutic cancer vaccines
|
Curigliano, Giuseppe |
|
2007 |
16 |
S2 |
p. 20-26 7 p. |
artikel |
18 |
Inflammation and cancer: Breast cancer as a prototype
|
Mantovani, Alberto |
|
2007 |
16 |
S2 |
p. 27-33 7 p. |
artikel |
19 |
Partial breast irradiation: Ready for routine?
|
Orecchia, R. |
|
2007 |
16 |
S2 |
p. 89-97 9 p. |
artikel |
20 |
Pathological definitions of invasion, metastatic potential and responsiveness to targeted therapies
|
Viale, Giuseppe |
|
2007 |
16 |
S2 |
p. 55-58 4 p. |
artikel |
21 |
Post-mastectomy radiation therapy: Translating local benefits into improved survival
|
Chung, Christine S. |
|
2007 |
16 |
S2 |
p. 78-83 6 p. |
artikel |
22 |
Pre-operative staging of breast cancer with breast MRI: One step forward, two steps back?
|
Kuhl, C. |
|
2007 |
16 |
S2 |
p. 34-44 11 p. |
artikel |
23 |
Safety of tibolone in the treatment of vasomotor symptoms in breast cancer patients—Design and baseline data ‘LIBERATE’ trial
|
Kubista, E. |
|
2007 |
16 |
S2 |
p. 182-189 8 p. |
artikel |
24 |
SUMMARY OF SESSION 5. LOCAL THERAPIES I: SURGERY
|
|
|
2007 |
16 |
S2 |
p. 71- 1 p. |
artikel |
25 |
Systemic adjuvant therapies and radiotherapy to the conserved breast: Strategies revisited
|
Bartelink, H. |
|
2007 |
16 |
S2 |
p. 84-88 5 p. |
artikel |
26 |
The dilemma of DCIS
|
Morrow, Monica |
|
2007 |
16 |
S2 |
p. 59-62 4 p. |
artikel |
27 |
The evolution of adjuvant endocrine therapy: Developments since St Gallen 2005
|
Smith, Ian E. |
|
2007 |
16 |
S2 |
p. 4-9 6 p. |
artikel |
28 |
The evolution of targeted biologic therapies
|
Sledge Jr, George W. |
|
2007 |
16 |
S2 |
p. 1-3 3 p. |
artikel |
29 |
The evolution of treatment strategies: Aiming at the target
|
Dinh, Phuong |
|
2007 |
16 |
S2 |
p. 10-16 7 p. |
artikel |
30 |
The prevalence of intrinsic subtypes and prognosis in breast cancer patients of different races
|
Kurebayashi, Junichi |
|
2007 |
16 |
S2 |
p. 72-77 6 p. |
artikel |
31 |
Using clinical trial data to tailor adjuvant treatments for individual patients
|
Regan, Meredith M. |
|
2007 |
16 |
S2 |
p. 98-104 7 p. |
artikel |
32 |
Using specific cytotoxics with a targeted mind
|
Di Leo, Angelo |
|
2007 |
16 |
S2 |
p. 120-126 7 p. |
artikel |